These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 22111533)
1. Design and application of locally delivered agonists of the adenosine A(2A) receptor. Mantell S; Jones R; Trevethick M Expert Rev Clin Pharmacol; 2010 Jan; 3(1):55-72. PubMed ID: 22111533 [TBL] [Abstract][Full Text] [Related]
2. Inhaled adenosine A(2A) receptor agonists for the treatment of chronic obstructive pulmonary disease. Mantell SJ; Stephenson PT; Monaghan SM; Maw GN; Trevethick MA; Yeadon M; Keir RF; Walker DK; Jones RM; Selby MD; Batchelor DV; Rozze S; Chavaroche H; Hobson TJ; Dodd PG; Lemaitre A; Wright KN; Stuart EF Bioorg Med Chem Lett; 2008 Feb; 18(4):1284-7. PubMed ID: 18243699 [TBL] [Abstract][Full Text] [Related]
3. Treating lung inflammation with agonists of the adenosine A2A receptor: promises, problems and potential solutions. Trevethick MA; Mantell SJ; Stuart EF; Barnard A; Wright KN; Yeadon M Br J Pharmacol; 2008 Oct; 155(4):463-74. PubMed ID: 18846036 [TBL] [Abstract][Full Text] [Related]
4. Highlights on the development of A(2A) adenosine receptor agonists and antagonists. Cristalli G; Cacciari B; Dal Ben D; Lambertucci C; Moro S; Spalluto G; Volpini R ChemMedChem; 2007 Mar; 2(3):260-81. PubMed ID: 17177231 [TBL] [Abstract][Full Text] [Related]
5. SAR of a series of inhaled A(2A) agonists and comparison of inhaled pharmacokinetics in a preclinical model with clinical pharmacokinetic data. Mantell SJ; Stephenson PT; Monaghan SM; Maw GN; Trevethick MA; Yeadon M; Walker DK; Selby MD; Batchelor DV; Rozze S; Chavaroche H; Lemaitre A; Wright KN; Whitlock L; Stuart EF; Wright PA; Macintyre F Bioorg Med Chem Lett; 2009 Aug; 19(15):4471-5. PubMed ID: 19501510 [TBL] [Abstract][Full Text] [Related]
6. Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor. Ribeiro A; Ferraz-de-Paula V; Pinheiro ML; Vitoretti LB; Mariano-Souza DP; Quinteiro-Filho WM; Akamine AT; Almeida VI; Quevedo J; Dal-Pizzol F; Hallak JE; Zuardi AW; Crippa JA; Palermo-Neto J Eur J Pharmacol; 2012 Mar; 678(1-3):78-85. PubMed ID: 22265864 [TBL] [Abstract][Full Text] [Related]
7. Adenosine receptors and neurological disease: neuroprotection and neurodegeneration. Stone TW; Ceruti S; Abbracchio MP Handb Exp Pharmacol; 2009; (193):535-87. PubMed ID: 19639293 [TBL] [Abstract][Full Text] [Related]
8. Advances in pharmacologic stress agents: focus on regadenoson. Johnson SG; Peters S J Nucl Med Technol; 2010 Sep; 38(3):163-71. PubMed ID: 20724531 [TBL] [Abstract][Full Text] [Related]
9. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study. Rimmer J; Peake HL; Santos CM; Lean M; Bardin P; Robson R; Haumann B; Loehrer F; Handel ML Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036 [TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
12. Chronic or high dose acute caffeine treatment protects mice against oleic acid-induced acute lung injury via an adenosine A2A receptor-independent mechanism. Li J; Li G; Hu JL; Fu XH; Zeng YJ; Zhou YG; Xiong G; Yang N; Dai SS; He FT Eur J Pharmacol; 2011 Mar; 654(3):295-303. PubMed ID: 21238452 [TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of novel dual-action compounds targeting the adenosine A(2A) receptor and adenosine transporter for neuroprotection. Chen JB; Liu EM; Chern TR; Yang CW; Lin CI; Huang NK; Lin YL; Chern Y; Lin JH; Fang JM ChemMedChem; 2011 Aug; 6(8):1390-400. PubMed ID: 21692183 [TBL] [Abstract][Full Text] [Related]